NCT06707805 Effects of Lumber Sustained Natural Apophyseal Glides on Lower Cross Syndrome
| NCT ID | NCT06707805 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Lower Cross Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 36 participants |
| Start Date | 2024-05-01 |
| Primary Completion | 2025-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 36 participants in total. It began in 2024-05-01 with a primary completion date of 2025-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A sustained natural apophyseal glide (SNAG) is a mobilization technique commonly used in the treatment of painful movement restrictions of the spine.Studing the effect of Lumber SNAGs in lower cross syndrome hold significance due to its potential to correct pain, hypomobility and biomechanical changes i.e hyperlordotic curve and anterior pelvic tilting caused by lower cross syndrome. The specific muscle imbalance seen in PCS gives rise to specific joint dysfunction, particularly in the L4-L5 and L5-S1 segment of the vertebral column. Over time, this causes stress at the L5-S1 segment of the vertebral column leading to pain and irritation in the lower back Lumber SNAGs encourage improvement of these repositioning error, posture, alleviate discomfort and enhance overall functioning. This research aims to offer patients a noninvasive and personalized approach to managing LCS, ultimately contributing to their overall well-being and movement quality
Eligibility Criteria
Inclusion Criteria: * Age 30 to 50 years. * Both genders * Patient came with the complain of low back pain. * Participants had to present with pain and hypomobility due to lower cross syndrome * Participants had to meet the criteria for lower cross syndrome indicating tight hip flexors and erector spinae along with weak abdominals and glutei muscles * Participants with hyperlordotic curve due to lower cross syndrome * Participants presenting with anterior pelvic tilting greater than angle \>7-10 degrees * Willing to provide informed consent to participate in study Exclusion Criteria:Participants contraindicated to spinal manipulation * Musculoskeletal pathologies affecting the lower back, pelvis, hips, or lower extremities (e.g., herniated disc, lumbar radiculopathy, lumbar stenosis, hip labral tear). * Participants who had undergone any lumber or pelvic surgery, as it will affect sacroiliac joint mechanics. * Generalized inflammatory or infective connective tissue disorder * Pregnancy
Contact & Investigator
Asmar Fatima, MS OMPT
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT06707805 clinical trial?
This trial is open to participants of all sexes, aged 30 Years or older, up to 50 Years, studying Lower Cross Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06707805 currently recruiting?
Yes, NCT06707805 is actively recruiting participants. Contact the research team at asmar.fatima@riphah.edu.pk for enrollment information.
Where is the NCT06707805 trial being conducted?
This trial is being conducted at Kotli, Pakistan.
Who is sponsoring the NCT06707805 clinical trial?
NCT06707805 is sponsored by Riphah International University. The principal investigator is Asmar Fatima, MS OMPT at Riphah International University. The trial plans to enroll 36 participants.